PET Radiopharmaceuticals Market Report

Global and China PET Radiopharmaceuticals Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 14, 2022
  • PAGES：209
  • REPORT CODE：GMM1373788
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the PET Radiopharmaceuticals industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • IBA Molecular Imaging (Belgium)

    • Advanced Accelerator Applications SA (France)

    • GE Healthcare (UK)

    • Mallinckrodt plc (Ireland)

    • Lantheus Medical Imaging, Inc (US)

    • Bayer AG (Germany)

    • Eczacibasi-Monrol Nuclear Products (Turkey)

    • Bracco Imaging SpA (Italy)

    • Cardinal Health Inc (US)

    • Nordion, Inc (Canada)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • F-18

    • Ru-82

    • Others

    Application:

    • Oncology

    • Cardiology

    • Neurology

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 PET Radiopharmaceuticals Industry Overview

      • 1.1.1 PET Radiopharmaceuticals Market Scope and Market Segments

      • 1.1.2 PET Radiopharmaceuticals Industry Characteristics

      • 1.1.3 Global and China PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China PET Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • 1.2 Global PET Radiopharmaceuticals Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 F-18

      • 1.2.2 Ru-82

      • 1.2.3 Others

    • 1.3 Global PET Radiopharmaceuticals Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Oncology

      • 1.3.2 Cardiology

      • 1.3.3 Neurology

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global PET Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global PET Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China PET Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China PET Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global PET Radiopharmaceuticals Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 PET Radiopharmaceuticals Industry Porter's Five Forces Model Analysis

      • 2.2.3 PET Radiopharmaceuticals Industry PEST Analysis

    • 2.3 PET Radiopharmaceuticals Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 PET Radiopharmaceuticals Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on PET Radiopharmaceuticals Industry

    Chapter 3 Global and China PET Radiopharmaceuticals Market, by Manufacturer

    • 3.1 Global and China PET Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China PET Radiopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China PET Radiopharmaceuticals Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China PET Radiopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China PET Radiopharmaceuticals Market Top 3 Players

    Chapter 4 Global and China PET Radiopharmaceuticals Market, by Type (2017-2028)

    • 4.1 PET Radiopharmaceuticals Market Trend, by Type

    • 4.2 Global PET Radiopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global PET Radiopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global PET Radiopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global PET Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • 4.3 China PET Radiopharmaceuticals Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China PET Radiopharmaceuticals Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China PET Radiopharmaceuticals Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China PET Radiopharmaceuticals Price Trend, by Type (2017-2028)

    Chapter 5 Global and China PET Radiopharmaceuticals Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global PET Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global PET Radiopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global PET Radiopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China PET Radiopharmaceuticals Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China PET Radiopharmaceuticals Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China PET Radiopharmaceuticals Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global PET Radiopharmaceuticals Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America PET Radiopharmaceuticals Market Analysis

    • 7.1 North America PET Radiopharmaceuticals Market, by Type

    • 7.2 North America PET Radiopharmaceuticals Market, by Application

    • 7.3 North America PET Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 7.3.1 United States PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe PET Radiopharmaceuticals Market Analysis

    • 8.1 Europe PET Radiopharmaceuticals Market, by Type

    • 8.2 Europe PET Radiopharmaceuticals Market, by Application

    • 8.3 Europe PET Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 8.3.1 Germany PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC PET Radiopharmaceuticals Market Analysis

    • 9.1 APAC PET Radiopharmaceuticals Market, by Type

    • 9.2 APAC PET Radiopharmaceuticals Market, by Application

    • 9.3 APAC PET Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 9.3.1 China PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa PET Radiopharmaceuticals Market Analysis

    • 10.1 Latin America, Middle East and Africa PET Radiopharmaceuticals Market, by Type

    • 10.2 Latin America, Middle East and Africa PET Radiopharmaceuticals Market, by Application

    • 10.3 Latin America, Middle East and Africa PET Radiopharmaceuticals Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina PET Radiopharmaceuticals Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China PET Radiopharmaceuticals Company Profiles

      • 11.1 IBA Molecular Imaging (Belgium)

        • 11.1.1 IBA Molecular Imaging (Belgium) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.1.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Advanced Accelerator Applications SA (France)

        • 11.2.1 Advanced Accelerator Applications SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.2.3 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 GE Healthcare (UK)

        • 11.3.1 GE Healthcare (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 GE Healthcare (UK) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.3.3 GE Healthcare (UK) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Mallinckrodt plc (Ireland)

        • 11.4.1 Mallinckrodt plc (Ireland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.4.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Lantheus Medical Imaging, Inc (US)

        • 11.5.1 Lantheus Medical Imaging, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.5.3 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Bayer AG (Germany)

        • 11.6.1 Bayer AG (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.6.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Eczacibasi-Monrol Nuclear Products (Turkey)

        • 11.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bracco Imaging SpA (Italy)

        • 11.8.1 Bracco Imaging SpA (Italy) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.8.3 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Cardinal Health Inc (US)

        • 11.9.1 Cardinal Health Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Cardinal Health Inc (US) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.9.3 Cardinal Health Inc (US) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Nordion, Inc (Canada)

        • 11.10.1 Nordion, Inc (Canada) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Nordion, Inc (Canada) PET Radiopharmaceuticals Product Profiles, Application and Specification

        • 11.10.3 Nordion, Inc (Canada) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 PET Radiopharmaceuticals Industry Investment Prospect and Risk Assessment

    • 12.1 PET Radiopharmaceuticals Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 PET Radiopharmaceuticals Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Global PET Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure China PET Radiopharmaceuticals Production Value and Growth Rate (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of F-18 (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of Ru-82 (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of Others (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of Oncology (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of Cardiology (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of Neurology (2017-2028)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate of Others (2017-2028)

    • Figure North America PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa PET Radiopharmaceuticals Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global PET Radiopharmaceuticals Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China PET Radiopharmaceuticals Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China PET Radiopharmaceuticals Sales Value, by Manufacturer (2021&2022)

    • Table Global and China PET Radiopharmaceuticals Market Share, by Manufacturer (2021&2022)

    • Figure Global and China PET Radiopharmaceuticals Market Share, by Manufacturer in 2021

    • Figure Global and China PET Radiopharmaceuticals Market Share, by Manufacturer in 2022

    • Table Global PET Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Global PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Value, by Type (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure Global PET Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Value, by Type (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Value Share, by Type (2017-2028)

    • Figure China PET Radiopharmaceuticals Price Trend, by Type (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Global PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Value, by Application (2017-2028)

    • Table Global PET Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure Global PET Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Value, by Application (2017-2028)

    • Table China PET Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Value Share, by Application (2017-2028)

    • Figure China PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure North America PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Europe PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure APAC PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa PET Radiopharmaceuticals Production, Import, Consumption and Export (2017-2022)

    • Table North America PET Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table North America PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure North America PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table North America PET Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table North America PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure North America PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure United States PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure United States PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Canada PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Canada PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Mexico PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Europe PET Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Europe PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Europe PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Europe PET Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Europe PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Europe PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Germany PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Germany PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure UK PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure UK PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure France PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure France PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Italy PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Italy PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Spain PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Spain PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Belgium PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Poland PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Poland PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Russia PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Russia PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Turkey PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table APAC PET Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table APAC PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure APAC PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table APAC PET Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table APAC PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure APAC PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure China PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Japan PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Japan PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure India PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure India PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Korea PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa PET Radiopharmaceuticals Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa PET Radiopharmaceuticals Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa PET Radiopharmaceuticals Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa PET Radiopharmaceuticals Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Brazil PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure South Africa PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Figure Argentina PET Radiopharmaceuticals Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina PET Radiopharmaceuticals Sales Value and Growth Rate (2017-2028)

    • Table IBA Molecular Imaging (Belgium) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table IBA Molecular Imaging (Belgium) Product Profiles, Application and Specification

    • Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Advanced Accelerator Applications SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Advanced Accelerator Applications SA (France) Product Profiles, Application and Specification

    • Table Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GE Healthcare (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GE Healthcare (UK) Product Profiles, Application and Specification

    • Table GE Healthcare (UK) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mallinckrodt plc (Ireland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mallinckrodt plc (Ireland) Product Profiles, Application and Specification

    • Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lantheus Medical Imaging, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lantheus Medical Imaging, Inc (US) Product Profiles, Application and Specification

    • Table Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG (Germany) Product Profiles, Application and Specification

    • Table Bayer AG (Germany) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) Product Profiles, Application and Specification

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bracco Imaging SpA (Italy) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bracco Imaging SpA (Italy) Product Profiles, Application and Specification

    • Table Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cardinal Health Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cardinal Health Inc (US) Product Profiles, Application and Specification

    • Table Cardinal Health Inc (US) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nordion, Inc (Canada) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nordion, Inc (Canada) Product Profiles, Application and Specification

    • Table Nordion, Inc (Canada) PET Radiopharmaceuticals Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US